Latest NewsStempeutics ties up with Cipla for its stem cell drugadminMay 18, 2018 May 18, 2018 Stempeutics has inked an out-licensing deal with Cipla, for its stem cell therapy product Stempeucel. It is suggested for treating critical limb ischemia. In a...